
Second Sight Medical Products EYES
Quarterly report 2025-Q3
added 11-13-2025
Second Sight Medical Products EV/EBITDA Ratio 2011-2026 | EYES
Annual EV/EBITDA Ratio Second Sight Medical Products
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.87 | -3.48 | 0.0567 | -1.44 | -3.63 | -1.66 | -9.09 | -11.4 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.87 | -11.4 | -3.35 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Medtronic PLC
MDT
|
24.4 | $ 86.87 | -0.34 % | $ 112 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.35 | -0.37 % | $ 21.8 M | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
-19.1 | $ 32.42 | 2.13 % | $ 1.49 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 36.53 | -0.27 % | $ 1.13 B | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 11.86 | -0.08 % | $ 470 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Electromed
ELMD
|
26.4 | $ 24.65 | 0.65 % | $ 208 M | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.68 | 0.86 % | $ 37 M | ||
|
Aethlon Medical
AEMD
|
-0.459 | $ 2.19 | -5.0 % | $ 3.42 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
11 | $ 11.31 | 9.06 % | $ 1.53 B | ||
|
Myomo
MYO
|
-2.96 | $ 0.71 | 0.04 % | $ 29.7 M | ||
|
Insulet Corporation
PODD
|
95.3 | $ 224.63 | -1.08 % | $ 15.8 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
-0.00869 | $ 2.38 | -2.66 % | $ 140 M | ||
|
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.85 | 3.08 % | $ 144 M | ||
|
Profound Medical Corp.
PROF
|
-7.43 | $ 5.2 | -3.7 % | $ 180 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 16.23 | -1.49 % | $ 381 M | ||
|
Penumbra
PEN
|
938 | $ 334.77 | -0.24 % | $ 13 B | ||
|
Outset Medical
OM
|
-14.9 | $ 3.5 | -3.32 % | $ 53.2 K | ||
|
Quanterix Corporation
QTRX
|
-14.7 | $ 3.72 | -5.58 % | $ 159 M | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 51.58 | -1.21 % | $ 1.51 B | ||
|
Pulmonx Corporation
LUNG
|
-22.5 | $ 1.36 | -2.52 % | $ 55.3 M | ||
|
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | ||
|
Varex Imaging Corporation
VREX
|
18.2 | $ 10.56 | -2.4 % | $ 437 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Sintx Technologies
SINT
|
0.974 | $ 2.58 | 1.18 % | $ 7.16 M | ||
|
InspireMD
NSPR
|
-1.11 | $ 1.77 | 2.32 % | $ 114 M | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
16.3 | - | - | $ 2.07 B |